Workflow for detection of ligands using nucleic acids

Patent metadata

Field	Value
Publication number	US-10472671-B2
Application number	US-201514955386-A
Country	US
Kind code	B2
Filing date	Dec 1, 2015
Priority date	Jan 17, 2011
Publication date	Nov 12, 2019
Grant date	Nov 12, 2019

Abstract

This application relates to methods for ligating oligonucleotides having complementarity to a target nucleic acid, and amplifying the ligated oligonucleotides, where ligation and amplification occur in the same reaction mixture.

First claim

What is claimed is:

1. A method for performing a proximity ligation assay on a test sample comprising:
a) contacting a target protein or analyte with at least a first probe and a second probe, each probe having binding specificity for the protein or analyte, and being adjoined to at least one type of DNA oligonucleotide to form a binding reaction mixture;
b) contacting the binding reaction mixture with a ligation-PCR reaction mixture comprising:
(i) a small-footprint DNA ligase (SFL) selected from the group consisting of a ligase of SEQ ID NO.: 77, a ligase of SEQ ID NO.: 78, a ligase of SEQ ID NO.: 79, a ligase of SEQ ID NO.: 80, a ligase of SEQ ID NO.: 81, a ligase of SEQ ID NO.: 82, and combinations thereof;
(ii) a splint oligonucleotide having a total length of less than 15 nucleotides, wherein said splint oligonucleotide is blocked at its 3′-end with a moiety that prevents polymerase activity;
(iii) at least one primer; and
(iv) a DNA polymerase,

c) ligating the oligonucleotides on the first and second probes to one another to produce a target nucleic acid;
d) amplifying the target nucleic acid; and
e) detecting the amplified target nucleic acid, wherein the ligation and amplification steps occur in a single reaction mixture.

2. The method of claim 1 , wherein at least one of said oligonucleotides on said first and second probes comprises at least three nucleotides.

3. The method of claim 1 , wherein said oligonucleotides on said first and second probes, are at least partially complementary to one another.

4. The method of claim 1 , wherein a portion of at least one of said probes is an antibody.

5. The method of claim 1 , wherein a portion of each of said first and second probes are antibodies.

6. The method of claim 1 , wherein the small footprint ligase is contacted with adenosine triphosphate (ATP) prior to use.

7. The method of claim 1 , wherein adenosine triphosphate is omitted from the reaction mixture in step b) and wherein the SFL is contacted with adenosine triphosphate prior to use in step b).

8. The method of claim 1 , wherein the ligated oligonucleotide is amplified using polymerase chain reaction (PCR).

9. The method claim 1 , wherein said amplified ligated oligonucleotide is detected using quantitative PCR (qPCR).

10. The method of claim 1 , wherein the 3′ and 5′ ends of the splint oligonucleotide are asymmetrical to one another.

11. The method of claim 1 , wherein said ligase is inactivated after ligation using a protease or heat.

12. A method for detecting a target in a sample comprising:
a) binding a first and a second probe, each of which binds specifically to the target, wherein each of the probes comprises a DNA oligonucleotide portion or tail;
b) adding a mixture to the binding reaction of step (a), the mixture comprising:
(i) a small-footprint DNA ligase (SFL) selected from the group consisting of, a ligase of SEQ ID NO.: 77, a ligase of SEQ ID NO.: 78, a ligase of SEQ ID NO.: 79, a ligase of SEQ ID NO.: 80, a ligase of SEQ ID NO.: 81, a ligase of SEQ ID NO.: 82, and combinations thereof;
(ii) a splint oligonucleotide having a total length of less than 15 nucleotides, wherein said splint oligonucleotide is blocked at its 3′-end with a moiety that prevents polymerase activity;
(iii) at least one primer; and
(iv) a DNA polymerase,

c) ligating the first and second oligonucleotide tails to produce a ligated oligonucleotide template; and
d) performing a polymerase chain reaction (PCR) of the oligonucleotide template across the first and second oligonucleotide to quantify the said template, wherein steps c) and c) are performed in the same reaction mixture.

13. The method of claim 12 , wherein the target is a protein or an analyte.

14. The method of claim 1 , wherein said splint oligonucleotide is blocked with a 3′amino linker group.

15. The method of claim 12 , wherein said splint oligonucleotide is blocked with a 3′amino linker group.

16. The method of claim 12 , wherein the 3′ and 5′ ends of the splint oligonucleotide are asymmetrical to one another.

17. The method of claim 1 , wherein the test sample comprises a cell lysate.

Assignees

• Life Technologies Corp

Inventors

• Chen Shiaw-Min
• Swartzman Elana
• Ruff David
• Shannon Mark
• Lu Julia
• Hendricks Stephen

Classifications

• C12Q1/6804 Primary

  Nucleic acid analysis using immunogens (immunoassay G01N33/53) · CPC title

• C12Q1/6855 Primary

  Ligating adaptors · CPC title

• C12Q2561/101

  Taqman · CPC title

• C12Q2561/125

  Ligase Detection Reaction [LDR] · CPC title

• C12Q2537/101

  Homogeneous assay format, e.g. one pot reaction · CPC title